Literature DB >> 23966057

Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.

Sukyoun Shin1, Hyunjong Song, Sang-Kwon Oh, Kyung Eob Choi, Ho Kim, Sunmee Jang.   

Abstract

Antihypertensive medication treatment is one effective management strategy to prevent cardiovascular disease (CVD) and mortality. However, little research has been conducted on the rates of antihypertensive medication adherence and the effect of antihypertensive medication adherence on health outcomes in South Korea. We searched the Korean National Health Insurance Claims Database for records from 2003 to 2007. Patients in this study were 18 years of age or older and they were diagnosed with hypertension and newly prescribed antihypertensive medication in 2003. Adherence to antihypertensive medication was estimated as the medication possession ratio (MPR). Multivariate Cox regression was used to evaluate the association between medication adherence and adverse health outcomes after adjusting for patient demographics and clinical characteristics. Our study population consisted of 40,408 patients with a mean age of 51 years. Among the patients, 50.3% were men, 4.0% had Medicaid health insurance, 17.8% had diabetes, 20.9% had dyslipidemia and 42.4% were adherent (MPR ≥ 80%). Nonadherent patients (MPR<80%) were younger and more likely to have Medicaid health insurance; they had lower rates of diabetes and dyslipidemia compared with adherent patients. In the Cox multivariate analysis, nonadherence increased the risk of all adverse health outcomes, including all-cause mortality and hospitalization for CVD (hazard ratio: 1.57, confidence interval: 1.40-1.76). In conclusion, our study indicates that medication adherence is important for reducing hospitalization due to CVD and mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966057     DOI: 10.1038/hr.2013.85

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  39 in total

1.  To overcome two diseases with one pill.

Authors:  Masaki Mogi; Masatsugu Horiuchi
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

2.  Safety and clinical outcome in combination therapy for high-risk elderly hypertensive patients.

Authors:  Seiji Umemoto
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

3.  Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases.

Authors:  Margret V Bjarnadottir; David Czerwinski; Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

4.  The association between adherence to cardiovascular medications and healthcare utilization.

Authors:  Tzahit Simon-Tuval; Noa Triki; Gabriel Chodick; Dan Greenberg
Journal:  Eur J Health Econ       Date:  2015-06-16

5.  Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real-world data analysis.

Authors:  Reed F Beall; Alexander A Leung; Amity E Quinn; Charleen Salmon; Tayler D Scory; Lauren C Bresee; Paul E Ronksley
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09-20       Impact factor: 2.885

6.  Achieving Adherence After First-Line Antihypertensive Treatment: Should Fixed-Dose Combinations Receive Priority?

Authors:  Kalyani B Sonawane Deshmukh; Jingjing Qian; Kimberly B Garza; Bradley M Wright; Peng Zeng; Cecilia M Ganduglia Cazaban; Richard A Hansen
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-24       Impact factor: 3.738

7.  Clinical outcomes and healthcare costs in hypertensive patients treated with a fixed-dose combination of amlodipine/valsartan.

Authors:  Ying-Chang Tung; Yu-Sheng Lin; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-12-05       Impact factor: 3.738

8.  Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.

Authors:  Marcel Halbach; David Grothaus; Fabian Hoffmann; Navid Madershahian; Kathrin Kuhr; Hannes Reuter
Journal:  Clin Auton Res       Date:  2020-02-12       Impact factor: 4.435

9.  Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.

Authors:  Takayuki Ishida; Akinori Oh; Shinzo Hiroi; Yukio Shimasaki; Nobuhiro Nishigaki; Takuya Tsuchihashi
Journal:  Hypertens Res       Date:  2018-11-16       Impact factor: 3.872

10.  Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.

Authors:  Marco Solmi; Jari Tiihonen; Markku Lähteenvuo; Antti Tanskanen; Christoph U Correll; Heidi Taipale
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.